Organization

University of Salerno

1 clinical trial

1 abstract

2 posters

Poster

PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy

Poster

Results from PIONEER: A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of Avapritinib in Patients with Indolent Systemic Mastocytosis

Clinical trial

Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients: a Randomized Crossover Trial

Status: Not yet recruiting, Estimated PCD: 2025-06-30

Abstract

BAG3 PROTEIN: A PROMISING NOVEL BIOMARKER OF FIBROSIS IN SYSTEMIC SCLEROSIS

Org: University of Salerno, FIBROSYS s.r.l., ASST Gaetano Pini-CTO, Dept of Rheumatology, Milan, Italy, University of Milano, European Institute of Oncology, Division of Early Drug Development, Research Center for Adult and Pediatric Rheumatic Diseases,